Skip to content
TrialScanner

NCT01214174

Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients

Phase 2TerminatedICLRLead

Registry record

Lead sponsor
ICON Bioscience Inc
Conditions
Ocular Inflammation
Primary completion
May 2012Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01214174 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.